Sort
51,593 grants matching “hepatitis”
Non-parenchymal Liver Cell Core
$406,766Hidekazu Tsukamoto · University Of Southern California · R24 · FY2013 · AA
Project 2-Optimization of Post-Transplant care via Biomarkers and Behavioral Interventions
$406,763Mary E McCaul · Johns Hopkins University · P50 · FY2019 · AA
Project 2-Optimization of Post-Transplant care via Biomarkers and Behavioral Interventions
$406,763Mary E McCaul · Johns Hopkins University · P50 · FY2023 · AA
Project 2-Optimization of Post-Transplant care via Biomarkers and Behavioral Interventions
$406,762Mary E McCaul · Johns Hopkins University · P50 · FY2021 · AA
Single Well MPCR Donor Screen to ID Blood Pathogens
$406,757Raymond Ranken · Ibis Biosciences, Inc. · R44 · FY2009 · HL
Epidemiology of Oncogenic Viruses
$406,743Thomas R O'Brien · Division Of Cancer Epidemiology And Genetics · ZIA · FY2019 · CA
Development of Preventative and Therapeutic HCV Vaccines
$406,659Vaccine Research Institute Of San Diego · R01 · FY2004 · AI
Cognitive and Inflammation Targeted Gut-Brain Interventions in People Living with HIV who are High-Risk Alcohol Users
$406,625Eric Porges · University Of Florida · P01 · FY2022 · AA
Mechanisms underlying hepatic immune cell recruitment in nonalcoholic fatty liver disease
$406,609Reben Raeman · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · DK
Novel Therapeutic Approaches for Eliminating Hepatitis B Virus DNAs and RNAs
$406,599Anton P McCaffrey · University Of Iowa · R01 · FY2010 · AI
Project 3: Peripheral and Central Molecular Clocks in Feeding, Sleep and Metabolic Aging
$406,534Fred W Turek · Northwestern University At Chicago · P01 · FY2021 · AG
RANDOMIZED HEPATITIS B VACCINE DELIVERY TRIAL FOR IDUS
$406,525University Of California San Francisco · R01 · FY2000 · DA
Hydrolytic enzymes in the metabolism of toxins
$406,522Bruce D Hammock · University Of California At Davis · R01 · FY2015 · ES
Exploring the dynamics of nsp1 and RNA interaction in SARS-CoV with undergraduate researchers
$406,504Anita Nag · University Of South Carolina · R15 · FY2023 · AI
The role of PAS kinase in hepatic lipid metabolism
$406,502Jared P Rutter · University Of Utah · R01 · FY2010 · DK
The Role of Hepatocyte ABCA1 in Lipid Mobilization and Transport
$406,485John S Parks · Wake Forest University Health Sciences · R01 · FY2014 · HL
PRESCIENT: A phase IIc, open-label, randomized controlled trial of ultra-short course bedaquiline, clofazimine, pyrazinamide and delamanid versus standard therapy for drug-susceptible tuberculosis
$406,451Serena Patricia Koenig · Brigham And Women'S Hospital · U01 · FY2025 · AI
Inhalable amphotericin B nanodisk therapy for aspergillosis in HIV-infected patie
$406,373Trudy M Forte · Lypro Biosciences, Inc. · R44 · FY2008 · AI
Role of SAA in Inflammation and Immunity
$406,330Richard D Ye · University Of Illinois At Chicago · R56 · FY2010 · AI
Role of TAZ in metabolic regulation in both normal and insulin resistant states
$406,311Ji Miao · Boston Children'S Hospital · R01 · FY2025 · DK
Therapeutic roles of hepatocyte exosomes in the liver
$406,282David R Brigstock · Research Inst Nationwide Children'S Hosp · R01 · FY2021 · AA
H19 long noncoding RNA in hepatic gluconeogenesis regulation
$406,276Yingqun Huang · Yale University · R01 · FY2018 · DK
Glycans in Hepatocellular Carcinoma
$406,276Radoslav Goldman · Georgetown University · R01 · FY2010 · CA
HIV, DRUG USE AND HEPATITIS C PATHOGENESIS
$406,266Johns Hopkins University · R01 · FY2002 · DA
2/4-American Consortium of Early Liver Transplantation-Prospective Alcohol-associated liver disease Cohort Evaluation (ACCELERATE-PACE)
$406,250Marina Serper · University Of Pennsylvania · R01 · FY2023 · AA